FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a...
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine - Moderna
WEBI am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccine for this fall for individuals 12 years of age and older. The updated vaccine composition targets the KP.2 variant, based on …
The FDA just approved the new Covid vaccine: When to get it ... - NBC News
WEBAug 22, 2024 · The Food and Drug Administration on Thursday approved the new Covid vaccines from Pfizer and Moderna. It’s the third time the vaccines have been updated to match circulating strains since the...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
WEBSep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines …
Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine ...
WEBSep 6, 2023 · Clinical trial data from research assay confirmed Moderna's updated COVID-19 vaccine showed an 8.7 to 11-fold increase in neutralizing antibodies against circulating variants, including BA.2.86, EG.5, and FL.1.5.1 variants.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to …
WEBSep 11, 2023 · FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
News Details - Moderna
WEBMar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
Moderna COVID-19 Vaccine | FDA
WEBNov 1, 2023 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older.
Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 ...
WEBNov 16, 2020 · An interim review of trial data suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults.
Peer-reviewed report on Moderna COVID-19 vaccine publishes
WEBDec 30, 2020 · The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine.
Skip to content